{
    "clinical_study": {
        "@rank": "124249", 
        "arm_group": [
            {
                "arm_group_label": "Hemodialysis group", 
                "description": "Patients on chronic hemodialysis program"
            }, 
            {
                "arm_group_label": "Peritoneal dialysis group", 
                "description": "Patients on chronic peritoneal dialysis program"
            }, 
            {
                "arm_group_label": "Pre-dialysis group", 
                "description": "Patients with chronic kidney disease stage-4"
            }, 
            {
                "arm_group_label": "Control group", 
                "description": "Healthy volunteers"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators aimed to study the effect of prohepcidin levels on hematologic parameters\n      and inflammatory markers in non-diabetic uremic patients. The investigators selected three\n      groups of patients: Hemodialysis group, peritoneal dialysis group and the group with stage 4\n      chronic kidney disease. A control group was formed from healthy volunteers also. Each group\n      has been planned to be formed of about 25 patients. Diabetic patients were excluded.\n      Prohepcidin, hsCRP, IL-6, fibrinogen have been planned to be studied besides other routine\n      biochemical analysis including hematological ones."
        }, 
        "brief_title": "Role of Prohepcidin in Uremic Patients", 
        "completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Inflammation", 
            "Chronic Kidney Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  hemodialysis and peritoneal dialysis patients who had been on dialysis therapy for\n             more than 3 months,\n\n          -  age between 18-80 years,\n\n          -  patients with creatinine clearance between 15-30 ml/min.\n\n        Exclusion Criteria:\n\n          -  age less than 18 or more than 80,\n\n          -  diabetic patients,\n\n          -  current active infectious or inflammatory disease."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "We selected three groups of patients: Hemodialysis group, peritoneal dialysis group and\n        the group with stage 4 chronic kidney disease. A control group was formed from healthy\n        volunteers also."
            }
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01735773", 
            "org_study_id": "HEPCIDIN-HASEKI"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hemodialysis", 
            "inflammation", 
            "iron", 
            "peritoneal dialysis", 
            "prohepcidin", 
            "uremia"
        ], 
        "lastchanged_date": "November 27, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Istanbul", 
                    "country": "Turkey", 
                    "zip": "34390"
                }, 
                "name": "Haseki Training and Research Hospital"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "4", 
        "official_title": "The Relationship of Prohepcidin Levels With Anemia and Inflammatory Markers in Non-diabetic Uremic Patients: A Controlled Study", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Prohepcidin levels will be compared with other inflammatory markers.", 
            "measure": "prohepcidin level", 
            "safety_issue": "No", 
            "time_frame": "Six months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01735773"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Correlations of prohepcidin levels with anemia and inflamatory markers", 
            "measure": "Anemia and inflammatory markers", 
            "safety_issue": "No", 
            "time_frame": "Six months"
        }, 
        "source": "Haseki Training and Research Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Haseki Training and Research Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}